Bacillus Calmette-Guerin (BCG) vaccine reprograms human neonatal metabolism in vivo and in vitro

被引：0

作者：

Arce, Joann Diray ^{[1
]}

Jensen, Kristoffer Jarlov ^{[2
,3
,4
]}

Angelidou, Asimenia ^{[1
]}

Conti, Maria Giulia ^{[1
]}

Kelly, Rachel S. ^{[5
]}

Pettengill, Matthew ^{[6
]}

Liu, Mark ^{[1
]}

van Haren, Simon D. ^{[1
]}

Benn, Christine Stabell ^{[7
,8
,9
]}

Ozonoff, Al ^{[1
]}

Steen, Hanno ^{[1
,10
]}

Lasky-Su, Jessica ^{[5
]}

Levy, Ofer ^{[1
,11
]}

机构：

[1] Harvard Med Sch, Boston Childrens Hosp, Precis Vaccines Program, Boston, MA 02115 USA

[2] Tech Univ Denmark, Dept Bio & Hlth Informat, Lyngby, Denmark

[3] Statens Serum Inst, Copenhagen, Denmark

[4] INDEPTH Network, Bandim Hlth Project, Bissau, Guinea Bissau

[5] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA

[6] Thomas Jefferson Univ, Philadelphia, PA 19107 USA

[7] INDEPTH Network, Bandim Hlth Project, Copenhagen, Denmark

[8] Univ Southern Denmark, Odense, Denmark

[9] Tech Univ Denmark, Dept Hlth Technol, Lyngby, Denmark

[10] Boston Childrens Hosp, Dept Pathol, Boston, MA USA

[11] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA

来源：

JOURNAL OF IMMUNOLOGY | 2020年 / 204卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

168.3

引用

页数：2

共 50 条

[1] Bacille Calmette-Guerin vaccine reprograms human neonatal lipid metabolism in vivo and in vitro
Diray-Arce, Joann
Angelidou, Asimenia
Jensen, Kristoffer Jarlov
Conti, Maria Giulia
Kelly, Rachel S.
Pettengill, Matthew A.
Liu, Mark
van Haren, Simon D.
McCulloch, Scott D.
Michelloti, Greg
Idoko, Olubukola
Consortium, Epic
Kollmann, Tobias R.
Kampmann, Beate
Steen, Hanno
Al Ozonoff
Lasky-Su, Jessica
Benn, Christine S.
Levy, Ofer
CELL REPORTS, 2022, 39 (05):
[2] Bacillus Calmette-Guerin (BCG): the adroit vaccine
Adesanya, Oluwafolajimi A.
Uche-Orji, Christabel, I
Adedeji, Yeshua A.
Joshua, John, I
Adesola, Adeniyi A.
Chukwudike, Chibuike J.
AIMS MICROBIOLOGY, 2021, 7 (01): : 96 - 113
[3] The bacillus Calmette-Guerin (BCG).
不详
BRITISH MEDICAL JOURNAL, 1928, 1928 (01): : 230 - 230
[4] The lipids of the bacillus Calmette-guerin (BCG).
Chargaff, E
HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1933, 217 : 115 - 137
[5] CANCER AND BCG (BACILLUS CALMETTE-GUERIN)
RUMI, LS
ACTA PHYSIOLOGICA LATINOAMERICANA, 1981, 31 (01) : 25 - 34
[6] BACILLUS CALMETTE-GUERIN (BCG) ENDOPHTHALMITIS
LESTER, H
ERDEY, RA
FASTENBERG, DM
SCHWARTZ, PL
ROSENHAUS, JB
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1988, 8 (03): : 182 - 184
[7] Uses and outcomes of the bacillus Mycobacterium bovis Calmette-Guerin (BCG vaccine)
LopezAntunano, FJ
SALUD PUBLICA DE MEXICO, 1997, 39 (02): : 156 - 161
[8] Lenalidomide augments the efficacy of bacillus Calmette-Guerin (BCG) immunotherapy in vivo
Jinesh G., Goodwin
Lee, Eugene Kang
Tran, Jonathan
Kamat, Ashish M.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (08) : 1676 - 1682
[9] A study of the pathogenicity of the bacillus of Calmette-Guerin (BCG)
Feldman, WH
AMERICAN JOURNAL OF PATHOLOGY, 1932, 8 (06): : 755 - U39
[10] MODULATION OF IMMUNITY BY BACILLUS CALMETTE-GUERIN (BCG)
MITCHELL, MS
MURAHATA, RI
PHARMACOLOGY & THERAPEUTICS, 1979, 4 (02) : 329 - 353

← 1 2 3 4 5 →